Editorial: Genetic and proteomic biomarkers in solid tumor detection and treatment

Jitian Li; Apeng Chen; Ruowen Zhang; Changwei Li; Jianguo Zhou

doi:10.3389/fgene.2023.1200660

Editorial: Genetic and proteomic biomarkers in solid tumor detection and treatment

Front Genet. 2023 May 11:14:1200660. doi: 10.3389/fgene.2023.1200660. eCollection 2023.

Authors

Jitian Li¹, Apeng Chen², Ruowen Zhang³, Changwei Li⁴, Jianguo Zhou⁵

Affiliations

¹ Laboratory of Molecular Biology, Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital), Zhengzhou, China.
² Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
³ Jiahehongsheng (Shenzhen) Health Industry Group, Shenzhen, China.
⁴ School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
⁵ University of Erlangen Nuremberg, Erlangen, Germany.

No abstract available

Keywords: detection; genetic biomarker; proteomic biomarker; solid tumor; treatment.

Publication types

Editorial

Grants and funding

This editorial was supported by the Innovation Fund of National Clinical Research Center for Orthopedics, Sports Medicine, and Rehabilitation (Grant No. 2021-NCRC-CXJJ-PY-13), the Young Elite Scientists Sponsorship Program by CAST (Grant No. 2021-QNRC2-A06), and the project of health guiding plan in Luoyang (Grant No. 2101043A).